Inventor
SHIRAI JUNYA
JP28 patents
⚠️ This page may combine multiple inventors who share the name “SHIRAI JUNYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
13 patentsUS10472376B2Nov 12, 2019
Amide compound
TAKEDA PHARMACEUTICALS CO5 citations83
US9573903B2Feb 21, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations83
USRE48334EDec 1, 2020
Nitrogen-containing heterocyclic compound and use of same
TAKEDA PHARMACEUTICALS CO1 citations72
US10000488B2Jun 19, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO3 citations72
US11851449B2Dec 26, 2023
Heterocyclic amide compounds having an RORvt inhibitory action
TAKEDA PHARMACEUTICALS CO0 citations62
USRE49686EOct 10, 2023
Nitrogen-containing heterocyclic compound and use of same
TAKEDA PHARMACEUTICALS CO0 citations62
US11053262B2Jul 6, 2021
Heterocyclic amide compounds having RORyT inhibitory action
TAKEDA PHARMACEUTICALS CO1 citations62
US9630924B2Apr 25, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations62
US11495331B2Nov 8, 2022
Document creation assistance server and document creation assistance method
TAKEDA PHARMACEUTICALS CO0 citations56
US10093629B2Oct 9, 2018
Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
TAKEDA PHARMACEUTICALS CO0 citations51
US9650343B2May 16, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations51
US9834520B2Dec 5, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations50
US10053468B2Aug 21, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations41
SHIRAI JUNYA
3 patentsTAKEDA PHARMACEUTICAL
3 patentsCARDURION PHARMACEUTICALS LLC
3 patentsUS10543212B2Jan 28, 2020
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC10 citations80
US11197858B2Dec 14, 2021
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC0 citations59
US11130752B2Sep 28, 2021
Aminopyrimidine compound
CARDURION PHARMACEUTICALS LLC0 citations49
CARDURION PHARMACEUTICALS INC
2 patentsUS12528816B2Jan 20, 2026
Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitors
CARDURION PHARMACEUTICALS INC0 citations59
US11795172B2Oct 24, 2023
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors
CARDURION PHARMACEUTICALS INC0 citations59